2 most recent filings and news items mentioning ASMB. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/ASMB/news?limit=20"
Pull ASMB filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayAssembly Biosciences launched an underwritten public offering of 3.36 million shares of common stock and pre-funded warrants to purchase 415,000 shares, with Guggenheim Securities and UBS as lead underwriters. The offering provides capital for the biotech company's operations and
View filing at SEC.gov →Assembly Biosciences announced expansion of its oral NTCP inhibitor ABI-6250 into primary biliary cholangitis and primary sclerosing cholangitis, with a Phase 2 study anticipated to initiate in Q1 2027. The expansion addresses significant unmet medical needs in cholestatic liver
View filing at SEC.gov →